vs
Astrana Health, Inc.（ASTH）与MARINEMAX INC（HZO）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是MARINEMAX INC的1.9倍（$950.5M vs $505.2M），Astrana Health, Inc.净利率更高（0.7% vs -1.6%，领先2.3%），Astrana Health, Inc.同比增速更快（42.9% vs 7.8%），MARINEMAX INC自由现金流更多（$8.3M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs -6.9%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
MarineMax Inc.是美国头部休闲船舶及游艇零售商，主营全新及二手休闲船艇销售，同时提供船舶维保、金融服务、保险、游艇租赁及航海主题活动等配套服务，覆盖北美市场的私人航海爱好者群体。
ASTH vs HZO — 直观对比
营收规模更大
ASTH
是对方的1.9倍
$505.2M
营收增速更快
ASTH
高出35.1%
7.8%
净利率更高
ASTH
高出2.3%
-1.6%
自由现金流更多
HZO
多$14.3M
$-6.0M
两年增速更快
ASTH
近两年复合增速
-6.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $505.2M |
| 净利润 | $6.6M | $-7.9M |
| 毛利率 | — | 31.8% |
| 营业利润率 | 1.9% | 1.0% |
| 净利率 | 0.7% | -1.6% |
| 营收同比 | 42.9% | 7.8% |
| 净利润同比 | 184.4% | -143.9% |
| 每股收益（稀释后） | $0.12 | $-0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHHZO
| Q4 25 | $950.5M | $505.2M | ||
| Q3 25 | $956.0M | $552.2M | ||
| Q2 25 | $654.8M | $657.2M | ||
| Q1 25 | $620.4M | $631.5M | ||
| Q4 24 | $665.2M | $468.5M | ||
| Q3 24 | $478.7M | $563.1M | ||
| Q2 24 | $486.3M | $757.7M | ||
| Q1 24 | $404.4M | $582.9M |
净利润ASTHHZO
| Q4 25 | $6.6M | $-7.9M | ||
| Q3 25 | $373.0K | $-851.0K | ||
| Q2 25 | $9.4M | $-52.1M | ||
| Q1 25 | $6.7M | $3.3M | ||
| Q4 24 | $-7.8M | $18.1M | ||
| Q3 24 | $16.1M | $4.0M | ||
| Q2 24 | $19.2M | $31.6M | ||
| Q1 24 | $14.8M | $1.6M |
毛利率ASTHHZO
| Q4 25 | — | 31.8% | ||
| Q3 25 | — | 34.7% | ||
| Q2 25 | — | 30.4% | ||
| Q1 25 | — | 30.0% | ||
| Q4 24 | — | 36.2% | ||
| Q3 24 | — | 34.3% | ||
| Q2 24 | — | 32.0% | ||
| Q1 24 | — | 32.7% |
营业利润率ASTHHZO
| Q4 25 | 1.9% | 1.0% | ||
| Q3 25 | 2.0% | 2.5% | ||
| Q2 25 | 3.1% | -6.3% | ||
| Q1 25 | 3.3% | 3.6% | ||
| Q4 24 | 0.1% | 8.3% | ||
| Q3 24 | 5.9% | 4.8% | ||
| Q2 24 | 6.2% | 8.1% | ||
| Q1 24 | 7.5% | 3.7% |
净利率ASTHHZO
| Q4 25 | 0.7% | -1.6% | ||
| Q3 25 | 0.0% | -0.2% | ||
| Q2 25 | 1.4% | -7.9% | ||
| Q1 25 | 1.1% | 0.5% | ||
| Q4 24 | -1.2% | 3.9% | ||
| Q3 24 | 3.4% | 0.7% | ||
| Q2 24 | 3.9% | 4.2% | ||
| Q1 24 | 3.7% | 0.3% |
每股收益（稀释后）ASTHHZO
| Q4 25 | $0.12 | $-0.36 | ||
| Q3 25 | $0.01 | $0.08 | ||
| Q2 25 | $0.19 | $-2.42 | ||
| Q1 25 | $0.14 | $0.14 | ||
| Q4 24 | $-0.14 | $0.77 | ||
| Q3 24 | $0.33 | $0.17 | ||
| Q2 24 | $0.40 | $1.37 | ||
| Q1 24 | $0.31 | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $164.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $932.8M |
| 总资产 | $2.2B | $2.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHHZO
| Q4 25 | $429.5M | $164.6M | ||
| Q3 25 | $463.4M | $170.4M | ||
| Q2 25 | $342.1M | $151.0M | ||
| Q1 25 | $260.9M | $203.5M | ||
| Q4 24 | $290.8M | $145.0M | ||
| Q3 24 | $350.3M | $224.3M | ||
| Q2 24 | $327.7M | $242.4M | ||
| Q1 24 | $337.3M | $216.7M |
总债务ASTHHZO
| Q4 25 | — | — | ||
| Q3 25 | — | $393.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $391.2M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ASTHHZO
| Q4 25 | $779.3M | $932.8M | ||
| Q3 25 | $775.5M | $937.2M | ||
| Q2 25 | $765.5M | $940.5M | ||
| Q1 25 | $745.4M | $993.4M | ||
| Q4 24 | $712.7M | $993.5M | ||
| Q3 24 | $704.6M | $975.8M | ||
| Q2 24 | $678.9M | $967.6M | ||
| Q1 24 | $653.5M | $931.3M |
总资产ASTHHZO
| Q4 25 | $2.2B | $2.4B | ||
| Q3 25 | $2.2B | $2.5B | ||
| Q2 25 | $1.4B | $2.5B | ||
| Q1 25 | $1.3B | $2.7B | ||
| Q4 24 | $1.4B | $2.6B | ||
| Q3 24 | $1.3B | $2.6B | ||
| Q2 24 | $1.3B | $2.6B | ||
| Q1 24 | $1.2B | $2.6B |
负债/权益比ASTHHZO
| Q4 25 | — | — | ||
| Q3 25 | — | 0.42× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.40× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $16.9M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $8.3M |
| 自由现金流率自由现金流/营收 | -0.6% | 1.7% |
| 资本支出强度资本支出/营收 | 0.3% | 1.7% |
| 现金转化率经营现金流/净利润 | -0.44× | — |
| 过去12个月自由现金流最近4个季度 | $104.5M | $184.7M |
8季度趋势，按日历期对齐
经营现金流ASTHHZO
| Q4 25 | $-2.9M | $16.9M | ||
| Q3 25 | $10.0M | $61.5M | ||
| Q2 25 | $90.9M | $84.9M | ||
| Q1 25 | $16.6M | $72.5M | ||
| Q4 24 | $-10.9M | $-146.1M | ||
| Q3 24 | $34.0M | $-782.0K | ||
| Q2 24 | $23.2M | $86.3M | ||
| Q1 24 | $6.0M | $-22.1M |
自由现金流ASTHHZO
| Q4 25 | $-6.0M | $8.3M | ||
| Q3 25 | $7.4M | $48.0M | ||
| Q2 25 | $89.5M | $68.5M | ||
| Q1 25 | $13.6M | $59.8M | ||
| Q4 24 | $-13.5M | $-164.4M | ||
| Q3 24 | $31.7M | $-17.5M | ||
| Q2 24 | $20.4M | $71.1M | ||
| Q1 24 | $5.6M | $-37.3M |
自由现金流率ASTHHZO
| Q4 25 | -0.6% | 1.7% | ||
| Q3 25 | 0.8% | 8.7% | ||
| Q2 25 | 13.7% | 10.4% | ||
| Q1 25 | 2.2% | 9.5% | ||
| Q4 24 | -2.0% | -35.1% | ||
| Q3 24 | 6.6% | -3.1% | ||
| Q2 24 | 4.2% | 9.4% | ||
| Q1 24 | 1.4% | -6.4% |
资本支出强度ASTHHZO
| Q4 25 | 0.3% | 1.7% | ||
| Q3 25 | 0.3% | 2.4% | ||
| Q2 25 | 0.2% | 2.5% | ||
| Q1 25 | 0.5% | 2.0% | ||
| Q4 24 | 0.4% | 3.9% | ||
| Q3 24 | 0.5% | 3.0% | ||
| Q2 24 | 0.6% | 2.0% | ||
| Q1 24 | 0.1% | 2.6% |
现金转化率ASTHHZO
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | 21.97× | ||
| Q4 24 | — | -8.09× | ||
| Q3 24 | 2.11× | -0.20× | ||
| Q2 24 | 1.21× | 2.74× | ||
| Q1 24 | 0.40× | -13.92× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
HZO
暂无分部数据
